Analyst Day Presentation_MASTER_09 19_Public V2

  • Upload
    mokilpo

  • View
    227

  • Download
    0

Embed Size (px)

Citation preview

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    1/85

    Towers Watson Analyst Day

    Welcome

    2013 Towers Watson. All rights reserved.

    September 20, 2013

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    2/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Forward-Looking Statements

    This document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You

    can identify these statements and other forward-looking statements in this document by words such as may, will, would, expect,

    anticipate, believe, estimate, plan, intend, continue, or similar words, expressions or the negative of such terms or other

    comparable terminology. Such statements are based upon the current beliefs and expectations of Towers Watson's management,

    and are subject to significant risks and uncertainties. Actual results may differ fromthose set forth in the forward-looking statements.

    The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: a

    decline in client demand (for example, resulting from the reduced use of defined benefit plans); the risk of a disclosure breach of

    company or client data; the ability to successfully make suitable acquisitions and divestitures; the risk that the acquisition of Extend

    Health is not profitable or is not otherwise successfully integrated; the ability to successfully address issues surrounding the numberof company shares that will become freely tradable on January 1, 2014; the risk that potential changes in federal and state health care

    regulations, or future interpretation of existing regulations, may have a material adverse impact on our business; the risk that our

    Exchange Solutions business fails to maintain good relationships with insurance carriers, becomes dependent upon a limited number

    of insurance carriers or fails to develop new insurance carrier relationships; the risk that changes and developments in the health

    insurance system in the United States could harm our business; our ability to respond to rapid technological changes; the ability to

    recruit and retain qualified employees and to retainclient relationships; and the risk that a significant or prolonged economic downturn

    could have a material adverse effect on Towers Watson's business, financial condition and results of operations. Additional risks and

    factors are identified under Risk Factors in Towers Watsons most recent Annual Report on Form 10-K filed with the SEC.

    You should not rely upon forward-looking statements as predictions of future events because these statements are based on

    assumptions that may not come true and are speculative by their nature. Towers Watson does not undertake an obligation to update

    any of the forward-looking information included in this document, whether as a result of new information, future events, changed

    expectations or otherwise.

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    2

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    3/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Non-GAAP Measures

    In order to assist readers of our financial statements in understanding the core operating results that the Company's managementuses to evaluate the business and for financial planning, we present (1) Adjusted EBITDA, (2) Adjusted Net Income Attributable toControlling Interests, (3) Adjusted Diluted Earnings Per Share and (4) Free Cash Flow (which are all non-U.S. GAAP measures). Weuse Adjusted EBITDA and Adjusted Diluted Earnings Per Share to eliminate the effect of acquisition-related expenses from thefinancial results of our operations. We use Adjusted Net Income Attributable to Controlling Interests (the numerator) for the purpose ofcalculating Adjusted Diluted Earnings Per Share. We use Free Cash Flow to represent cash provided by our operations that may beavailable for investing or for repaying debt. The Company believes that Adjusted EBITDA, Adjusted Diluted Earnings Per Share andFree Cash Flow are relevant and useful information widely used by analysts, investors and other interested parties in our industry toprovide a baseline for evaluating and comparing our operating results.

    We incurred significant acquisition-related expenses related to our merger and integration activities necessary to combine WatsonWyatt and Towers Perrin from the Merger in January 2010 through fiscal year 2013. These acquisition-related expenses includedtransaction and integration costs, severance costs, non-cash charges for amortization of intangible assets and merger-related stock-based compensation costs from the issuance of merger-related restricted shares. Acquisition-related gains include a gain resultingfrom the fair value adjustment to our investment in Fifth Quadrant upon the purchase of a controlling interest. Included in ouracquisition-related transaction and integration costs were integrationconsultant fees and legal, accounting, marketing and informationtechnology integration expenses.

    Although our merger and integration activities have been completed, we will continue to provide adjusted measures as we incur asignificant amount of amortization from acquired intangibles. We expect that this amortization will continue over the estimated usefullives of the related intangibles.

    We consider Adjusted EBITDA, Adjusted Diluted Earnings Per Share and Free Cash Flow to be important financial measures, whichwe use to internally evaluate and assess our core operations, and benchmark our operating results against our competitors. We use

    Adjusted EBITDA and Adjusted EPS to evaluate and measure our performance-based compensation plans. Adjusted EBITDA andAdjusted Diluted Earnings Per Share are important in illustrating what our operating results would have been had we not incurredthese acquisition-related expenses.

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    3

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    4/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Non-GAAP Measures

    We define Adjusted EBITDA as net income before non-controlling interests adjusted for provision for income taxes, interest, net,depreciation and amortization, transaction and integration expenses, acquisition related non-cash stock-based compensation, changein accounting method for pension, and other non-operating income. We define Adjusted Diluted Earnings Per Share as dilutedearnings per share from continuing operations adjusted for transaction and integration expenses, non-cash stock-basedcompensation, amortization of merger and acquisition accounting intangible assets, a change in accounting method for pension andother merger related items. We define Free Cash Flow as Cash Flows from Operating Activities less cash flows used for Fixed Assetsand Software for Internal Use, each of which is presented on the GAAP Consolidated Statements of Cash Flows. These non-U.S.GAAP measures are not defined in the same manner by all companies and may not be comparable to other similarly titled measuresof other companies. Non-U.S. GAAP measures should be considered in addition to, and not as a substitute for, the information

    contained within our financial statements.

    Reconciliations of Net Income before Non-Controlling Interests to Adjusted EBITDA; Diluted Earnings Per Share to Adjusted DilutedEarnings Per Share; and Cash Flow from Operating Activities to Free Cash Flow are available in our supplemental Analyst Day slideson our website in the Investor Relations > Financial Presentations section.

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    4

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    5/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Agenda

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    Time Session Speaker 9:30 a.m. Continental Breakfast

    10:00 a.m. Opening Remarks John Haley, Chief Executive Officer

    10:15 a.m. Risk and Financial ServicesPatricia Guinn, Managing Director, Risk andFinancial Services

    10:30 a.m. Talent and RewardsJulie Gebauer, Managing Director, Talent and

    Rewards

    10:45 a.m. Benefits Gene Wickes, Managing Director, Benefits

    11:00 a.m. Break

    11:15 a.m. Exchange SolutionsBen Pajak, SVP, Strategy and BusinessDevelopment, Exchange Solutions

    11:30 a.m. OneExchange

    Brian Tenner, SVP, Exchange Solutions

    David Osterndorf, Chief Health Actuary, NorthAmerica

    12:00 noonFinancial Overview andFY14 Guidance

    Roger Millay, Chief Financial Officer

    12:15 p.m. Q&A Session

    12:45 p.m. Lunch with Towers Watson Leaders5

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    6/85

    Towers Watson Analyst Day

    Opening Remarks

    2013 Towers Watson. All rights reserved.

    John Haley

    September 20, 2013

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    7/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    FY13 Performance

    l Top-line revenue growth: +5% constant currency, +4% organic growth

    l All segments ended the year with constant currency revenue growth

    l Adjusted diluted EPS $5.57, up 8% vs. FY12

    l Adjusted EBITDA 19.1%

    l Completed the Towers Watson integration effortsl Free cash flow of $453 million, an increase of 136% over FY12

    l Repurchased 838 thousand shares*

    7

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    *Shares repurchased under authority to offset dilution and authority to repurchase shares outside of the anti -dilutive authorization

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    8/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Drivers ofTowers Watson

    Business

    Globalization

    Human Capital Key toBusiness Success

    Economic Uncertainty

    Emerging Markets

    Legislative Issues

    Compliance, Accountingand Tax Regulations

    Industry-Specific Issues

    De-Risking

    Mergers and Acquisitions

    Complexity ofBenefit Plans

    Market drivers

    8

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    9/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Our strategy for continued growth

    9

    Our strategy is focused on profitable growth

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    InorganicGrowth

    l Expand core

    l Adjacent spaces

    Organic Growth

    l Market penetration

    l Emerging markets

    l Target marketapproach

    Innovation

    l Seed new capabilities

    l Disciplined approach

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    10/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Benefits

    l Health care cost and legislativeuncertainties

    l OneExchange Active HGB and TAS

    Talent and Rewards

    l Our work peaks with peak employment inthe economy

    l Emerging markets competition for talent

    l Technology

    Exchange Solutions

    l OneExchange Access

    l OneExchange Retiree

    l Fidelity channel partner

    Investment

    l Delegated investment solutions

    l Diversification of clients: insurers,endowments, foundations and sovereignfunds

    Key growth opportunities

    10

    Continued Inorganic and Strategic Solutions

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    11/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Towers Watson business

    11

    We offer solutions in the areas of benefits, talent management, rewards, andrisk and capital management

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    Benefitsl Retirement (38%)

    l Health and Group Benefits (8%)

    l Technology and AdministrationSolutions (7%)

    l International (2%)

    Risk and FinancialServicesl Risk Consulting and Software

    (11%)

    l Investment (6%)

    l Reinsurance and InsuranceBrokerage (5%)

    Talent and Rewardsl Rewards, Talent and

    Communication (6%)l Data, Surveys and Technology

    (6%)

    l Executive Compensation (4%)

    Exchange Solutionsl OneExchange Retiree (3%)

    l OneExchange Accessl New offering for FY14

    (seasonal, part-time,contract)

    FY13 split based on total company revenues

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    12/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Benefits Business drivers

    l Economic environment and changing risk appetite of pension providersleading to opportunities such as lump sum distribution and otherpension de-risking projects for the Retirement group

    l The complexity of changing regulations, such as the PPACA, iscreating work for Health and Group Benefits

    l Large plan benefits outsourcing driving Technology andAdministration Solutions revenue growth in EMEA and the U.S.

    l International Consulting Group helping multinational organizationsprovide global strategy, oversight and management of benefitprograms

    l OneExchangeActive: Expect enrollments to increase pace in 2015and 2016, and beyond

    12

    Expect low single digit growth for FY14

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    Benefits RFS

    T&RExchangeSolutions

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    13/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Risk and Financial Services Business drivers

    l In Risk Consulting and Software, insurance companies interest inanalytics, performance improvement and our leading risk and financialsoftware creates opportunities for us.

    l Investment opportunities are created through volatile economiesaround the globe as clients seek to improve their fund governance,

    control their risks and increase their returns.

    13

    Expect low to mid single digit decline for FY14

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    Benefits RFS

    T&RExchangeSolutions

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    14/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Talent and Rewards Business drivers

    l Solid project revenue

    l Intense market focus, need for benefits and HR program implementationsupport

    l Ongoing need for executive pay advisory services, compensation andworkforce benchmarking data

    l Increasing focus on HR technology

    l Differentiation through integration of technology and consultingsolutions

    14

    Expect mid single digit growth for FY14

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    Benefits RFS

    T&RExchangeSolutions

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    15/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Exchange Solutions Business drivers

    l OneExchange Retiree post- and pre-65 retirees

    l OneExchange Access seasonal, contractors, part-time

    l Contract with Centers for Medicare & Medicaid Services (CMS)

    l Partnership opportunities

    l The PPACA provides future opportunities to enter new markets

    15

    Expect around 60% growth for FY14

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    Benefits RFS

    T&RExchangeSolutions

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    16/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Strategic outlook

    l Increasing revenue at stable margins in our core business

    l Continue to leverage existing business portfolio

    l Expanded global target market focus

    l Organic and inorganic capability enhancement

    l

    Continue record of mid-single-digit revenue growth and double-digitEPS growth

    l Continued strong revenue stability

    l Stable base of recurring revenues

    l Strong client retention

    16

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    17/85

    Towers Watson Analyst Day

    Risk and Financial Services

    Tricia Guinn

    September 20, 2013

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    18/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Risk and Financial Services Business overview

    Profile

    l Investment Consulting and Solutions

    l Investment policy, governance and risk assessment

    l Investment strategy

    l Structured products design

    l Manager structure, selection, monitoring and evaluation

    l Delegated/implemented consulting

    l Risk Consulting and Software

    l Financial and regulatory reportingl Enterprise risk and capital management

    l M&A and corporate restructuring

    l Product and market strategies, including pricing

    l Financial modeling software and implementation support

    l Reinsurance and Insurance Brokerage

    l Discontinued operations as of Q1 FY14

    Revenue by Line of Business*

    Revenue by Geography*

    Reinsurance andInsurance Brokerage

    Risk Consulting andSoftware

    Investment Consultingand Solutions

    More than 50% of revenues are recurring

    FY14 Guidance (does not include impact of Brokeragesale)

    l Low-to mid-single-digit constant FX revenue decline

    NOI margin in the low- 20% range *FY13 split based on total RFS Segment revenue.FY13 constant currency revenue growth of 1%FY13 NOI margin of 22%

    2013 Towers Watson. All rights reserved.

    18

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    19/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    We have signed an agreement for JLT to acquire TowersWatsons global brokerage business

    l The combination of Towers Watsons (re)insurance brokerage businesswith JLT Re creates a $260+ million global business which is theclear #4 player in this space

    l JLT is committed to investing in this business to further grow in thisarea

    l Towers Watson and JLT will have an ongoing relationship to offer acompelling market proposition which will help drive revenue for bothorganizations

    2013 Towers Watson. All rights reserved.

    19

    towerswatson.com

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    20/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Towers Watson is a global leader in investment adviceand implementation

    20

    l Trusted advisor to institutional investors

    l Focus on liability-driven investing since 1990

    l European Pensions Fiduciary ManagementFirm of the Year 2012

    Our Firm

    l $2 trillion+ in global client assets underadvisement

    l ~$60 billion in delegated (outsourced) global

    assets

    l Diverse asset pools: pensions, insurance,sovereign funds, foundations and endowments

    l Over $100 bil lion in liability-driven investmentstrategies implemented

    Our Client Base

    l More than 750 associates across strategy,consulting and research disciplines

    Our People

    140+STRATEGYCONSULTANTS150+RESEARCHSPECIALISTS

    750+TOTAL INVESTMENT ASSOCIATES, INCLUDING:

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    21/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    The Investment business has a strong history of revenue growth

    $120

    $158$174

    $194 $195

    $208

    $225

    $0

    $50

    $100

    $150

    $200

    $250

    FY07 FY08 FY09 FY10 FY11 FY12 FY13

    Revenue ($ in Millions)

    towerswatson.com

    21

    Margins have generally been around the company average

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    22/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Increased Delegation

    Our business has moved from purely advisory to greaterdelegation/implementation

    towerswatson.com

    22

    l Current state and desired future state

    l Goals, risk tolerance/return objectives

    l Governance and roles/responsibilities

    l Stakeholder approach to change

    l Investment beliefs

    l Balance sheet/enterprise risk position

    l Liquidity and timing requirements

    l Tax/accounting/regulatory implications

    FlexiblePartnership

    Analytics Advisory Implementation

    OurCapabilities

    ClientNeeds

    Research ClientsFirst

    Insight

    Investment Servicesglobal depth and scale

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    23/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    We have a diverse delegated business

    towerswatson.com

    23

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    Towers Watson delegated assets under management as of July 2013 US$

    Towers Watson delegated client count by region and type July 2013

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    24/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    InvestmentServices

    Investment Insight Clients First

    The funds business is the next step in our journey alongthe responsibility spectrum

    towerswatson.com

    24

    Principles

    Tools Advice DelegationDelivery

    Implementation

    Pooled Funds Custom Portfolio

    2013 Towers Watson. All rights reserved.

    New!

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    25/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    25

    towerswatson.com

    Transformation work is another area of opportunity

    Missionand

    Beliefs

    ValueChain

    Culture

    RiskPolicy

    InvestmentManagementGlobal Best

    Practices

    OrganizationalDesign

    InvestmentManagement

    Cycle

    Bringing best practices to internal investment management

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    26/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    FY13 was a challenging year for the Risk Consultingand Software business

    l Continuation of EMEA financial crisis caused clients to decreasediscretionary consulting spend

    l Shelving of Solvency II requirements led to the deferral or cancellationof consulting projects, and meant we were overstaffed in EMEA

    l Lower level of demand led to intense competition for consulting

    business and severe pricing pressures

    l Lower level of M&A activity than prior year

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    26

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    27/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    While FY14 outlook is strong for Software, it remainsmixed for our consulting businesses

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    27

    Americas Consulting

    l Expect stable client demand

    l P&C/Corporate practices have a strongbase of recurring revenue and a goodpipeline

    l Life practice remains dependent on M&Aand will continue to be volatile

    Asia Pacific Consulting

    l Expect modest growth, but revenue inregion will continue to be volatile

    l Key growth areas are China, SoutheastAsia and insurance managementconsulting and UBI

    EMEA Consulting

    l Economic outlook remains uncertain

    l Anticipate continued depressed client

    demand

    Software

    l Expect continued growth driven byexpansion of sales force and new

    products

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    28/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Life Financial Modeling

    Our market-leading software solutions

    MoSes

    MoSes Azure (NEW)

    MoSes HPC

    RiskAgility MoSes

    RiskAgility

    Enterprise Modeling Platform

    RiskAgility EC

    Economic Capital

    P&C Pricing

    Classifier

    Emblem

    Optimiser

    Radar (NEW)

    Rate Assessor

    ResQ

    P&C Reserving

    Replica

    Replicating Portfolio

    P&C Capital Modeling

    Igloo

    Igloo Compact Edition

    Igloo DCC

    Igloo Enterprise

    Technology Consulting Services

    Global Alliance Partner

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    towerswatson.com

    28

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    29/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    We are taking action to align our business with marketdemand and improve profitability

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    29

    Revenue Enhancement Expense Reduction

    l Move to more sales-oriented culture

    l Recruit rainmakers to drive sales

    l Broaden out and raise value add

    of our servicesl Emphasize growth of annuity

    revenue

    l Align staffing with market demand

    l Drive delivery efficiency andimproved utilization

    l

    Prioritize product developmentefforts

    l Scale back certain investments

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    30/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    We continue to believe in the longer-term outlook forRisk Consulting and Software

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    Strong franchise

    Right vision for the business

    Taking appropriate action

    Need time to see results

    30

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    31/85

    Towers Watson Analyst Day

    Talent and Rewards

    Julie Gebauer

    September 20, 2013

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    32/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Revenue by Line of Business*

    Revenue by Geography*

    Talent and Rewards business overview

    32

    13%

    26%

    61%

    Asia Pacific

    EMEA

    Americas

    23%

    36%

    41%

    *FY13 split based on total T&R Segment revenueFY13 constant currency revenue growth of 2%FY13 NOI margin of 20%

    Profile

    l Rewards, Talent and Communication

    l Base pay and incentive design

    l Leadership services and talent management

    l Change management and communication strategy

    l Data, Surveys and Technology

    l Employee opinion surveys

    l Compensation benchmarking

    l HR technology implementation

    l Proprietary technology solutions to support HR processes

    l Executive Compensation

    l Executive pay philosophy and strategy development

    l Public disclosure development and technical reviews

    l Top executive compensation consultancy with over 300consultants in 35 offices in 16 countries providing advice toover 3,000 clients

    l

    Compensation data covering 110 countries, over 40industry sectors, 50 functions/job families and 9,900 jobs

    l Decades of experience surveying over 40 million employeesfrom more than 3,000 companies in more than 106 countries

    ExecutiveCompensation

    Rewards, Talent andCommunication

    Data, Surveys andTechnology

    2013 Towers Watson. All rights reserved. Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    FY14 Guidance

    Mid- single digit constant FX revenue growth NOI Margin in the low- to mid-20% range

    32

    towerswatson.com

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    33/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Greater opportunity for integratedprojects relative to point solutions in

    strong economy

    Talent and Rewards market proposition

    l Consulting in areas of strategic importance

    l Competing on differentiated value through:

    l Depth of expertise

    l Industry focus

    l Data and analytics

    l Delivering point solutions and appropriately linking complementarypractices

    l Within T&R: to provide complete solutions, from strategy to implementation

    l Across segments: to support the employee experience associated withdesign and administration of benefits and Exchange Solutions

    33

    FY14 mix of work expected tocreate stronger backlog and

    pipeline during year

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    34/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Focus for FY2014

    Key ingredients for profitable growth

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    Low-cost operationsStandardized processes

    Offshored resource center

    Close management of

    controllable costs

    High-performance standardsSales and delivery expectations

    Few pure management roles

    Annuity/product revenueBenchmarking data

    Employee attitude surveys

    SaaS

    New productized offerings

    Market-responsive staffing modelHiring just behind demand

    Staffing across boundaries

    Balance of FTEs/contractors

    Stablemargins

    Foundationfor growth

    34

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    35/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Current market conditions

    HR Consulting Budgets

    l Stable to modest increases in mature markets for target clients,partially due to minimal regulatory change

    l Meaningful increases in selected emerging markets

    HR Technology Budgets

    l Meaningful increases across markets

    l But relatively small portion of our T&R portfolio

    Implementation Support

    l

    Strong demand related to pension changes, PPACA, ExchangeSolutions (retiree and active exchanges)

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    35

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    36/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Regional variations

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    l Ongoingdemand

    for HRtechnology

    l Ongoing need forbasic HR consulting

    l Low to moderatedemand for HRconsulting l Moderate demand for

    basic HR consultingl New pull for HR

    technology

    l Continuing needfor implementationsupport

    l Selectedopportunity fortechnology sales

    36

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    37/85

    Towers Watson Analyst Day

    Benefits Segment

    Gene Wickes

    September 20, 2013

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    38/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Benefits business overview

    38

    Revenue by Line of Business*

    3%

    30%

    67%

    Asia Pacific

    EMEA

    Americas

    4%

    13%

    15%

    68%

    *FY13 split based on total Benefits Segment revenue.FY13 constant currency revenue growth of 5%FY13 NOI margin of 34%

    Revenue by Geography*

    Profile

    l Retirement

    l Strategy and plan design

    l De-Risking

    l Actuarial services, compliance and governance strategies

    l Defined contribution solutions

    l Health and Group Benefits

    l Program strategy, design and pricing

    l OneExchange Active

    l Wellness, Rx Collaborativel Vendor evaluation, selection and management

    l Technology and Administration Solutions

    l Pension and retirement plan administration

    l Health and welfare administration

    l OneExchange Active

    l International

    l Cost and risk control solutions for employee benefit plans

    globally

    l Provides actuarial services to more of the worlds top300 pension funds than any other professional servicesfirm

    International

    Retirement

    Health and Group Benefits

    Technology andAdministration Solutions

    2013 Towers Watson. All rights reserved. Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    FY14 Guidance

    Low- single- digit constant FX revenue growth NOI Margin in the low-to mid - 30% range 38

    towerswatson.com

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    39/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Retirement outlook: Overview of pension de-riskingmarket

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    Liability-DrivenAsset Strategies

    Plan TerminationTraditionalOngoing Plans

    Close Plan toNew Entrants

    Freeze BenefitAccruals

    ProspectiveLump Sum Option

    Bulk LumpSums (Former

    Employees)

    Bulk LumpSums (Retirees)

    AnnuityPurchases

    IncreasedFunding

    Account-BasedPlans

    Spectrum of Pension De-Risking Actions

    39

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    40/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Retirement outlook: Leading indicators U.S. August2013

    40

    Indicator July 31, 2013De-Risking

    Assessment

    Interest Rates l High-quality corporate bond indices generally unchanged during July and +70-80 bps YTD

    l Long-term Treasuries +8-12 bps during July and +70-80 bps YTD

    Funded Status

    l Strong equity market performance during July and YTD (S&P 500 +19.62%, Russell 2500+22.96%, EAFE +9.60%)

    l

    YTD funded status improvement for many sponsors in the +10-15% range (although manysponsors still underfunded on a plan termination basis)

    Market Movers

    l Significant uptick in de-risking activity

    l Sponsors proceeding with lump sum programs during 2013 contemplating delay until early2014 given interest rate movements

    l Limited activity (but significant potential) in mega ($1B+) annuity market

    Accounting/RegulatoryChange

    l Verizon class-action lawsuit dismissed by Texas court

    l Subsequent retiree lump sum PLRs under review by IRS we are aware of a PLR underreview since mid-2012 with no response

    l IRS-sponsored research being conducted regarding de-risking activities

    Innovation

    l Continued annuity marketplace evolution

    l Settlement readiness initiative gaining traction

    l Plan termination initiative under way to better coordinate delivery approach

    Change from/toFavorable Emerging Unfavorable

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    41/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Benefits outlook: EMEA

    l Regulatory changes in the UK and Netherlands

    l Auto enrollment

    l New Pension Accord

    l Launch of Premium Pension Institute

    l Design and execution of new market standard for DC plans

    l Launch of health care practice

    l Increasing demand and costs of retirement and health care provisions

    l Economic crisis and demographic changes increasing pressure to reducestate pension and health care provision

    l Grow Benefits Brokerage business

    l Launch Data Solution services

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    41

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    42/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    HGB North America outlook

    l Towers Watson is helping clients continue with self-managed programsor access high performance plans via OneExchange Active

    l Investments in OneExchange: Impact on Utilization

    l Working with carriers to develop high performance plans

    l HGB associates involved with Access and Retirees sales

    l Client education and analysis regarding active market

    l Long term revenue prospects:

    l We have good prospects either path a client selects; self-managedprograms or OneExchange.

    l OneExchange shifting of revenue source, greater market share is

    expected

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    Client demand is being driven by the imperative to have high-performing healthand welfare programs to enable affordable coverage for employees,

    to maintain a healthy workforce and to avoid the 2018 excise tax.

    42

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    43/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    TAS outlook

    North America

    l Active market anticipated for benefits administration/outsourcing

    l Health and Welfare market activity expected to be very robust in 2014 and forthe next few years

    l DB market activity is expected to be strong

    l Strong selling season in 2013 impacting 2014 revenues due to deferralaccounting

    EMEA

    l UK and Germany continue to be active markets for pension administrationoutsourcing

    l Slower pace than last year but some big long-term opportunities

    l Very well placed competitively with biggest market share of top 100/200 privatesector funds in UK and market leader in Germany

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    TAS well-positioned for growth

    43

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    44/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    OneExchange

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    44

    FY14 enrollment

    period ends

    FY15 enrollment

    period begins

    FY14Q1

    FY14Q2

    FY14Q3

    FY14Q4

    FY15Q1

    FY15Q2

    FY15Q3

    FY15Q4

    $'s

    Revenue Expense

    FY14 all investment/revenue inguidance

    FY15 and beyond expect profitat company average

    TAS/HGB

    Retiree

    PopulationsCOBRA

    Part-TimeEmployees

    Active

    Employees

    OneExchangeActive

    OneExchangeAccess

    OneExchangeRetiree

    Seasonal

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    45/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Global Health and Group Benefits Solutions (GHGB)

    l Client demand for GHGB consulting and brokerage is increasing as clients expand theirglobal footprint and health care cost increases continue to reach high single digits

    l Building on the success of our HGB businesses in North America and the U.K., we arecontinuing to expand our health and group benefits business to meet our clients emerging

    needs

    l The overall market size outside of North America and the U.K. for these types of services isapproximately $700M, and represents a dynamic market opportunity for Towers Watson.

    0%

    2%

    4%

    6%

    8%

    10%

    12%

    Global Asia Pacific Europe Latin America Middle East North America

    2011

    2012

    Health Care Cost Increases by Region

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    45

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    46/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Global Health and Group Benefits Solutions (GHGB)

    l Looking ahead to FY14, our plan is to:l Set up HGB businesses and obtain brokerage licenses in seven additional

    countries

    l Work with several major insurance companies to create prepackaged solutionsfor our clients in key countries where they dont have critical mass to justifycustom approaches

    l

    Engage a limited number of pilot clients on a global basis as we build out ourcapabilities

    l The FY14 revenues and investments are included in the FY14 guidance.l System development approximately $500,000

    l Net investment on P&L approximately $2-3 million.

    l This is a multiyear project for Towers Watson estimates suggestprofitability in line with Segment margins within three years. Profitable asof second year.

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    46

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    47/85

    Towers Watson Analyst Day

    Exchange Solutions

    2013 Towers Watson. All rights reserved.

    Ben Pajak

    September 20, 2013

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    48/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Exchange Solutions Business Overview

    48

    0%

    0%

    100%

    Asia Pacific

    EMEA

    Americas

    Revenue by Geography

    Profile

    l Private Exchange infrastructure (Extend Healthacquired in 2012)

    l Largest private Medicare insurance exchange

    l 10% of Fortune 500

    l 400,000+ Medicare plan participants

    l Patented technology platforml Growing Individual market, pre Medicare, population

    l Partnerships with third party advisors andadministrators, i.e., Fidelity

    l Most Exchange Solutions revenues come from thecommissions we receive from insurance carriers

    l Over the long term, NOI margin is expected to be atleast in the mid-20% range

    2013 Towers Watson. All rights reserved. Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    FY14 Guidance

    Revenue growth around 60% Low 20% NOI Margin

    48

    FY13 proforma* revenue growth of 58%FY13 proforma** NOI margin of 26%

    *as if Towers Watson owned Extend Health for entire FY12 andexcluding purchase accounting revenue adjustments in FY12 and FY13**excluding purchase accounting revenue adjustments in FY13

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    49/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Significant growth opportunity for Exchange Solutions

    49

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    Medicare-Eligible Retirees With Employer-Sponsored Coverage

    TowersWatson

    Others

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    50/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Exchange Solutions: Business drivers

    l Continued interest and focus on Medicare exchange business(rebranded as OneExchange Retiree)

    l Pre-Medicare individual market offering (OneExchange Access)launched on a pilot basis for this open enrollment period (OEP 14)

    l Entered into contract with Centers for Medicare & Medicaid Services(CMS) to participate in the Federally Facilitated Marketplace (FFM)

    l Fidelity relationship signed in February; showing results

    l Retail partnership pilot (50 stores in CA, FL, TX) rolling out October 1

    50

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    51/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Exchange Solutions: Medicare eligible retiree market

    l Coming off a very strong OEP 2013 enrollment year

    l Notable client wins last year

    l Dupont, The Goodyear Tire & Rubber Company, Ingersoll-RandCompany, Bridgestone/Firestone

    l Signed largest retiree client in company history (IBM)

    l Partnering closely with other LOBs and segments to launch theOneExchange offering and drive growth

    51

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    52/85

    Video in progress

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    53/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    OneExchange delivers value to your entire population

    53

    Retiree

    Populations

    Part-TimeEmployees

    COBRA

    Active

    Employees

    OneExchangeActive

    OneExchangeAccess

    OneExchangeRetiree

    Seasonal

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    54/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Connecting individuals to new Marketplaces

    All state and federal exchanges

    All Carriers

    Right AnswerRight Coverage

    Best Price

    Employer-ProvidedAccess

    OneExchange Benefit Advisors

    State State FFE

    State State FFE

    l Subsidy Optimization

    l Transition Services

    l Public Exchanges

    l Personalization

    l Carrier and ExchangeConnectivity

    l Advocacy

    OneExchange Access Part-time employees, seasonal workers, COBRA eligibles

    OneExchange Retiree Early Retirees (Pre-65, not Medicare eligible)

    54

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    55/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Web broker agreement with federal government

    l Signed agreement with the Centers for Medicare & Medicaid Services

    l Exchange platform will integrate with federal eligibility systems

    l Allows ability to assist individuals and sell plans on the federal exchange

    l Single destination in all 36 states served by the federal exchange

    55

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    56/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    OneExchange Access: Marketplace map 2015 OEP

    56

    WA

    OR

    CA

    NV

    ID

    UT

    AZ

    MT

    TX

    NM

    AK

    HI

    CO

    WY

    NE

    OK

    KS

    ND*

    SD

    MI*

    WI

    MN

    IA

    MO

    AR

    LA

    INIL

    OH

    KY

    TN

    MS AL

    FL

    GA

    SC

    NC

    VAWV

    MD

    DE

    PA

    ME

    NH

    VT

    RI

    NY

    CT

    NJ

    MA

    DC

    n Full Integration Enrollment (36)n Web Portal Integration Enrollment (14)n Guidance Referral Only (1)

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    57/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Retail partnership pilot overview

    l Three-state, 50-store programl Co-branded, in-store health

    education center (kiosk) staffedby Towers Watson

    l Eligibility/appointment tool will

    reside within each kiosk

    l Pre- and post-65 insuranceoptions in pilot states

    l Post-65 insurance options only innon-pilot states

    l Several marketing programs

    planned to drive online traffic

    towerswatson.com

    57 2013 Towers Watson. All rights reserved.

    NV

    CO

    ND

    KS

    OK

    MD

    VT

    MA

    CT

    CA

    OR

    WA

    UT

    ID

    AZ NM

    WY

    MT

    SD

    MN

    IA

    NB

    MO

    TX

    AR

    MS

    AL

    TN

    KY

    GA

    NC

    SC

    FL

    WV

    PA

    NY

    NH

    ME

    ILIN

    OH

    WI

    MI

    LA

    ND

    NV

    CO

    KS

    OK

    VA

    MD

    Pilot states; Pre and post-65 insurance options

    National program; Post-65 insurance options only

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    58/85

    Towers Watson Analyst Day

    OneExchange

    2013 Towers Watson. All rights reserved.

    Dave OsterndorfBrian Tenner

    September 20, 2013

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    59/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Health care benefits evolution

    l The objective of the acquisition was to enhance the capabilities of both organizations

    l is one result of that collaboration and brings together:

    l The leading retiree exchange

    l

    Leading group health and welfare outsourcing technology and administration process*l Market-leading health care consulting

    l Benefit change management expertise

    l Total compensation expertise

    l The acquisition also deepened and enhanced both Towers Watson and Extend Healths:

    l Carrier and client relationships

    l Technology platforms and administrative processes

    59

    *Sources: International Association of Outsourcing Professionals, 2013 Global Outsourcing List; Everest Group, 2013 Benefits AdministrationOutsourcing Report

    The acquisition of Extend Health brought together the expertise ofTowers Watsons core benefits business with the market leading Medicare exchange.

    OneExchange is developed, managed and maintainedentirely by Towers Watson.

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    60/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    OneExchange delivers value to any or all of an employerspopulations

    RetireePopulationsCOBRA

    Part-TimeEmployees

    ActiveEmployees

    OneExchangeActive

    OneExchangeAccess

    OneExchangeRetiree

    Delivers transitionassistance for

    full-time employeepopulations moving to

    our high-performingexchange-based plans

    Delivers transition assistancefor part-time and other (e.g.,

    seasonal) employees toindividual market plans on

    public and private exchanges

    Delivers transition assistance forpost- and pre-65 retirees

    moving from employer-sponsoredhealth care coverage to individual

    Medicare market plans, or publicand private exchanges

    Seasonal

    Createspositive behavior change, andimproved physical and financialwell-being

    Accessesnew/increased federal funding

    Connectsto lower-cost risk pool andmore federal money

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    60

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    61/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    How will participants and companies find value in exchanges?

    61

    Towers Watson has the know-how and capability to connectemployees and retirees to value in exchanges

    Value opportunities foremployers and participants

    OneExchange

    Access Active Retiree

    Use other peoples money

    Make people healthier

    Create better consumers

    Reduce company workload

    Make it personal/higher

    employee satisfaction

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    62/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Market Opportunity for Exchange Offerings

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    62

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    63/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    OneExchange Access and Retiree facilitate the transition fromgroup to individual

    Platinum

    OneExchange Access orRetiree

    l Contracts with/providespreferred plans

    l Supports communications andenrollment

    l Administers employer subsidies(where applicable)

    Participantsl Evaluate preferred options

    l Elect coverage

    l Work with OneExchange toresolve issues

    Gold

    Silver

    Employer

    CensusLimited

    interaction

    Plans*

    Bronze

    Catastrophic

    Ancillary

    63

    Funding(optional)

    *Public Marketplace plans shown other options use private market offerings (e.g., Medicare ret iree Medigap/MA/Part D plans)

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    64/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    EligibilityDetermination forFederal Subsidy

    Application Dispatched to Carrier

    Public Marketplace QHPsWith Federal Subsidy

    OneExchange Access enrollment process

    64

    Application Dispatchedto Public Marketplace

    Public MarketplaceQHPs Without

    Federal Subsidy

    PrivateExchange

    QHPs

    Eligible Ineligible

    Early Retiree/Non-FT Employee

    +

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    65/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Towers Watson role and compensation Access/Retiree

    Towers Watson is responsible for:

    Companies save time and money by providing participants with thisalternative enrollment process and access to greater market choice.

    Connection tohealth plans

    Participanteducation/enrollmentsupport

    Ongoingparticipantadvocacy

    Commissions from carriers Client fees

    Towers Watson is compensated through:

    OneExchange is developed,

    managed and maintained byTowers Watson.

    65

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    66/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Objectives in building an exchange for actives

    The exchange should incorporatebest practices*

    l Ongoing medical trend at halfor less than median of all companies

    l Contracting strategies rewardhigher-performing network providers

    l Better purchasingthrough cost-consciousness

    l Proactive management of high-cost casesthrough robust support and engagement

    l Increased employee accountabilityties financial outcomes to actions

    66

    *2013 TW/NBGH Employer Survey on Purchasing Value in Health Care; Results of Best Performers

    Getting to high performance can be a buy rather than build strategy

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    67/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    OneExchange Active: Our private exchange model

    Multiple national carriers

    Four plan design choices

    Primarily self-funded plans in 2014 with employerchoice in funding in future years

    High-value design elementsWellness, care/Rx management, transparency and more

    Ancillary productsDental and vision

    Consumer-

    GuidedEnrollmentExperience

    Enrollment and

    OngoingAdministrationPlatform

    The goal: Deliver a high-value, sustainable framework

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    67

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    68/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Savings opportunities: OneExchange Active

    68

    Best-in-market discount/contracting arrangements

    High-performance Rxstructure and contracting

    Sophisticated caremanagement programs

    Year 1savings projections are

    substantial, without cost-shifting

    Medical and pharmacycontracting terms

    Health promotion/improvement linked tofinancial incentives

    Improved consumerchoices

    Connects physical andfinancial well-being

    Ongoingtrend approximately half ofprevailing national levels

    $

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    69/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Directed fees inself-insured healthplans

    Commissions infully insured healthplans and otherancillary/welfarebenefit plans

    Success-sharingarrangements

    Towers Watson role and compensation Active

    Towers Watson is responsible for:

    69

    Carriers on theplatform

    Plan designs,clinicalmanagement,Rx programs,operationalelements

    Fundingapproaches,networkconfigurations,cost managementstrategies

    Towers Watson is compensated through:

    The magnitude of total benefit savings is expected to be substantial, andTowers Watson compensation is easily ROI-justified for clients.

    OneExchange is developed,managed and maintainedby Towers Watson

    OneExchange is developed,managed and maintained byTowers Watson.

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    70/85

    Towers Watson Analyst Day

    Financial Overview and FY14 Guidance

    2013 Towers Watson. All rights reserved.

    Roger Millay

    September 20, 2013

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    71/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    $5.57

    FY13FY11

    $4.46

    +25%

    Strong Historical Performance

    71

    l Continued strong growth acrosskey initiatives

    l Strong acquisition performance

    Revenue

    About $7B

    $3.3B

    Sep 13Jul 10

    Over 100%

    $688M

    $616M

    FY13FY11

    18.9%

    19.1%

    +12%

    Adj. EBITDARevenues

    Adj. EPS Market Capitalization

    $3.60B

    FY13FY11

    $3.26B

    Earnings Leverage

    l Disciplined operating marginmanagement

    l Industry-leading margins

    l Significant EPS leverage

    Cash & ShareholderReturn

    l Generated ~$1.1B in free cashflow and returned ~$280 million toshareholders through repurchasesand dividends since July 2010

    +10%

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    72/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Efficient Capital Structure

    72

    (US$ millions) 6/30/2013

    Cash and Short-Term Investments $ 589

    Total Debt $ 250

    Accrued Retirement Benefits/Other Employee-Related Liabilities

    $ 771

    Total Towers Watson Equity $ 2,724

    Balance Sheet

    l $461 million cash available for use as of 6/13

    l Predominantly outside of U.S.

    l At lower end of targeted debt to EBITDARratio of 2 to 3 times (rating agency basis)

    l As of 6/30/13, no balance on $500million revolver

    l $250 million outstanding term loan,matures 6/1/17

    l Decrease in Retirement liability due toincreased discount rate and payments/contributions

    l ~71 million diluted shares

    l Share unlock overhang has beenmanageable, with no significant pressure onthe stock, 5.4 million shares remain

    Solid Balance Sheet

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    73/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Efficient Capital Structure

    73

    Cash Flow from Operations Free Cash Flow

    $316M

    $531M

    +68%

    FY13

    Improvement driven by receivables recovery, integration wind-down and businessperformance

    Pension contributions a $90 million Headwind in FY13 but will be approximately a$50 million Tailwind in FY14

    Going forward, we expect free cash flow to be in the neighborhood of adjusted netincome

    $192M

    $453M

    +136%

    FY12 FY13

    FY12

    Strong Free Cash Flow Growth

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    74/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Capital Allocation Priorities

    towerswatson.com

    2013 Towers Watson. All rights reserved.

    Reinvest in

    Business

    RepurchaseShares

    Dividends

    Acquisitions

    Targeting dividendpayout ratio of 10%

    OneExchange platform

    Global Benefits Brokerage

    Seed new capabilities

    OneExchange platform

    Global Benefits Brokerage

    Seed new capabilities

    We expect to continueto make targetedacquisitions to enhanceour competitive position

    Approximately $120 million

    remains available onClass A stock repurchaseauthorization

    Expect more consistentrepurchasing

    74

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    75/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Reinsurance and Insurance Brokerage Sale

    l FY14 guidance provided in this presentation does not include theimpact of the sale. The following information provides some additionalcontext to the guidance in relation to the sale:

    l Expected close date FY14 Q2 various regulatory approvals required.

    l This will be treated as a discontinued operation for Q1.

    l FY13 revenues $166 million, 53% weighting in second half of fiscal year.l Gain/Loss transaction may result in either.

    l Likely dilutive to EPS and margins from continuing operations specificsnot yet determined.

    l Allocation of cash proceeds will assess the cash needs of thecompany but overall we anticipate becoming more active in share

    repurchases.

    l Will provide an update on the next earnings call.

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    76/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    TW Guidance - UpdateFirst Quarter Fiscal 2014

    Revenues expected to be around the low end of the range of $850 to$870 million

    Adjusted diluted EPS* expected to be within the range of $1.36 to $1.41

    EBITDA margin in the range of 18.0% - 18.5%

    Income tax rate* around 24%

    Diluted shares outstanding of approximately 71 million

    *Includes $15 million of resolved tax examinations

    76

    2013 Towers Watson. All rights reserved.

    Guidance does not include impact of Brokerage Sale

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    77/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Segment Guidance - UpdateFirst Quarter Fiscal 2014

    77

    Q1 FY13Constant Currency

    Growth RateReported Currency

    Growth RateNOI Range

    Benefits $457 about flat about flat around 30%

    Risk and FinancialServices $192 mid single digitdecline mid single digitdecline mid teens

    Talent and Rewards $140mid- to high- single

    digitmid- to high- single

    digitlow- to mid- 20%

    Exchange Solutions $ 14 around 145% around 145% high single digit

    2013 Towers Watson. All rights reserved.

    Guidance does not include impact of Brokerage Sale

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    78/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    FY14 Guidance Full Year

    Revenues around $3.7 billion

    Adjusted diluted EPS* expected to be within the range of $5.90 to$6.00

    EBITDA margin in the range of 19.0% - 19.5%

    Income tax rate* around 32%

    Capital expenditures within the range of $95 million to $100 million

    Diluted shares outstanding of approximately 71 million

    Guidance assumes a monthly average exchange rate of 1.00 =US$1.55 and 1.00 = US$1.32

    78

    *Includes $15 million of resolved tax examinations

    2013 Towers Watson. All rights reserved.

    Guidance does not include impact of Brokerage Sale

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    79/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Segment Guidance Full Year FY14

    79

    FY13Constant Currency

    Growth RateReported Currency

    Growth RateNOI Range

    Benefits $1,994 low single digit low single digit low- to mid- 30%

    Risk and FinancialServices

    $ 812low- to- mid single

    digit declinelow- to- mid single

    digit declinelow 20%

    Talent and Rewards $ 573 mid single digit mid single digit low- to mid- 20%

    Exchange Solutions $ 95 around 60% around 60% low 20%

    2013 Towers Watson. All rights reserved.

    Guidance does not include impact of Brokerage Sale

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    80/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Strong Financial Profile

    Significant recurring revenues

    Consistent margins

    Diversified client base

    Largest client relationship

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    81/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    towerswatson.com

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    82/85

    Towers Watson Analyst Day

    Appendix

    September 20, 2013

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    83/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Fiscal 2013 Impact of Reserve Methodology Change

    towerswatson.com 2013 Towers Watson. All rights reserved.

    NOI Margin Q1 FY13 Q2 FY13 Q3 FY13 Q4 FY13

    Reported Impact Reported Impact Reported Impact Reported Impact

    Benefits 30% 1% 36% 0% 35% 0% 34% 0%

    Risk and Financial Services 19% 0% 22% 0% 29% 0% 15% 1%

    Talent and Rewards 18% 1% 34% 0% 11% 1% 11% -1%

    Exchange Solutions -41% 0% -64% 0% 48% 0% 51% 0%

    NOI Margin Full Year FY13

    Reported Impact

    Benefits 34% 0%

    Risk and Financial Services 22% 0%

    Talent and Rewards 20% 0%

    Exchange Solutions 17% 0%

    Beginning in FY14 Towers Watson has aligned the segment reserving methodology with the GAAP reservingmethodology. This table provides the impact to FY13 NOI margins as if in FY13 Towers Watson had followed the newreserving methodology.

    83

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    84/85

    Proprietary and Confidential. For Towers Watson and Towers Watson client use only.

    Todays Speakers

    Julie Gebauer Julie Gebauer is Managing Director, Talent and Rewards. During her 26 years with the company, she has held a

    number of leadership roles, including U.S. East Division leader, and head of the global workforce effectiveness andemployee survey businesses. She is a Fellow of the Society of Actuaries.

    Patricia Guinn Patricia Guinn is Managing Director, Risk and Financial Services. She joined Towers Perrin in 1976. Patricia is aFellow of the Society of Actuaries, a member of the American Academy of Actuaries and a Chartered Enterprise Risk

    Analyst. She currently serves as a board member of the International Insurance Society.

    John Haley John Haley is Chairman and Chief Executive Officer. John joined Watson Wyatt in 1977 and became the consultingactuary to several of Watson Wyatts largest clients. He negotiated the strategic alliance with Watsons in the U.K. and,in 1995, he was appointed the leader of the global retirement practice. He was named Watson Wyatts chief executiveofficer in 1998. Under his leadership, the company went public in 2000, and completed two historic mergers, in 2005and 2010, that formed present-day Towers Watson. John also serves on the board of directors of MAXIMUS and

    Hudson Global, Inc. He is a Fellow of both the Society of Actuaries and the Conference of Consulting Actuaries, andhas servedas a trustee of The Actuarial Foundation.

    Roger Millay Roger Millay is Vice President and Chief Financial Officer. Roger has more than 25 years of experience in financialofficerpositions, including roles at Airgas, Arthur Young & Company, Citigroup, Discovery and GE Capital.

    Dave

    Osterndorf

    Dave Osterndorf is Chief Health Actuary, North America. Dave joined Towers Perrin in 1989 and leads our healthactuarial practice in both policy/practices and product development activities. He is a Fellow of the Society of Actuariesand a member of the American Academy of Actuaries.

    Ben Pajak Ben Pajak is Senior Vice President, Strategy and Business Development, Exchange Solutions, and is a leader ofthe OneExchange health benefit solution. Prior to the acquisition of Extend Health, Ben served as a business leader for

    Towers Watsons Health and Group Benefits practice. Ben joined Towers Perrin in 2003 and became a Principal in2007.

    Brian Tenner Brian Tenner is Senior Vice President, Exchange Solutions. Since 2004 Brian has led sales and businessdevelopment for major market segments. Brian has held executive level leadership positions at Ceres Group andHewitt Associates.

    Gene Wickes Gene Wickes is Managing Director, Benefits. Gene has 34 years of experience consulting on retirement, actuarial,plan administration and other human resource issues. He is a Fellow of the Society of Actuaries and an enrolledactuary under ERISA.

    towerswatson.com

    84

    2013 Towers Watson. All rights reserved.

  • 7/27/2019 Analyst Day Presentation_MASTER_09 19_Public V2

    85/85

    Towers Watson Leaders

    85

    Jim Foreman Jim Foreman is Managing Director, Americas. He also is a member of the companys executive committee. Heworked for more than 20 years at Towers Perrin in a number of leadership posi tions, which inc luded globa lresponsibilities.

    Carl Hess Carl Hess is Managing Director, Investment. He joined the Watson Wyatt in 1989. He has worked with many of theworlds largest institutional investors over his 30 years of experience. Carls areas of expertise include asset allocation,risk budgeting, pension finance and governance. Carl is a Fellow of both the Society of Actuaries and the Conferenceof Consulting Actuaries, and is a Chartered Enterprise Risk Analyst.

    Mark Maselli Mark Maselli is Managing Director, Health and Group Benefits, North America. He has 30 years of experienceconsulting on health and welfare, retirement, plan administration and other benefits areas. Mark is an Associate in theSociety of Actuaries and a member of the American Academy of Actuaries.

    Paul Morris Paul Morris is Managing Director, Europe, Middle East and Africa. Previously, he served as Director, ConsultingServices for Towers Watson and was a Managing Consultant in Watson Wyatt. He is a Fellow of the Society of

    Actuaries and a Member of the Institute of Actuaries.

    Mark Reid Mark Reid is Managing Director, Talent and Rewards, Europe, Middle East and Africa. Mark joined the firm in1991 in London and qualified as a Fellow of the Institute of Actuaries. He has spent most of his career working in thefield of executive compensation, primarily advising board compensation committees, working in both the U.S. andEurope.